CASSANDRA CLENDENEN: Open Payments
NPI 1508598194 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 42 payments from 14 companies in 2025. Trend: 2023 $858 · 2024 $673 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $175 |
| ABBVIE INC. | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| PFIZER INC. | 3 | $57 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Exact Sciences Corporation | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
Products named: FARXIGA, QULIPTA, SHINGRIX, Wegovy, Ozempic, Rybelsus, INSPIRE, Cologuard Collection Kit.
Industry payments across TN — which companies pay providers there.
